Unconventional Medicine Bonus Chapter

UNCONVENTIONAL
MEDICINE  
BONUS CHAPTER
unconventionalmedicinebook.com 1
Introduction
Dear Reader,
Thank you for downloading the Unconventional Medicine bonus chapter.
Throughout my book, I talk a lot about the concepts of Functional Medicine and ancestral diet and lifestyle. But
concepts are of limited value until you can practically apply them. That’s where this bonus chapter comes in.
In the following three case studies, you’ll be able to see just how powerful Functional Medicine and ancestral
health can be when applied to real-life patients:
■ How blood sugar control was restored in a 66-year-old patient with diabetes
■ How rheumatoid arthritis in a 46-year-old patient was resolved by treating the gut
■ How hypothyroidism was resolved in a 26-year-old patient by restoring iodine levels
I hope these case studies give you a greater insight into how digging deeper and resolving the root cause of
chronic illness can result in true healing rather than symptom supression.
In health,
Chris Kresser
Inflammatory Joint Pain and Hormone
Imbalance Resolved by Treating the Gut
CASE SUMMARY
A 46-year-old female experienced a downward spiral after the death of a loved one and the loss of her job.
She complained of joint pain, gastrointestinal symptoms, cold hands and feet, problems thinking,
anxiety, and insomnia. She had been given a diagnosis of rheumatoid arthritis but did not want to take
immunosuppressive drugs. Routine lab tests, HLA-B27, a stool test, SIBO, and hormone panels showed
thyroid dysfunction and genetic predisposition to autoimmunity. She also had high iron levels and gut
dysbiosis. Especially noteworthy was an overgrowth of Klebsiella, a bacteria known to contribute to
inflammatory joint disease. Treating Michelle’s dysbiosis resolved her joint pain, improved her cognitive
function, and normalized her thyroid markers and cortisol levels.
Michelle, a 46-year-old female, presented with bilateral joint pain in the hands and feet, digestive symptoms
(gas, bloating, constipation), cold hands and feet, brain fog, anxiety, and sleep disturbance. Her symptoms
had worsened in the last three-month period, after she lost her job and her mother passed away.
She had been given a provisional diagnosis of rheumatoid arthritis by another clinician. She was prescribed
immunosuppressive drugs, which she refused. She occasionally took ibuprofen to manage the joint pain, but
she was concerned about its long-term effects. She had a family history of autoimmune disease (her mother
had Hashimoto’s thyroiditis and her sister had Crohn’s disease). She believed that she might also have some
form of autoimmunity.
I ran a full panel of lab tests on Michelle: a stool test, HLA-B27 blood test, small intestinal bacterial
overgrowth breath test, urinary organic acids, routine lab tests with a thyroid panel, and a urine hormone
profile. I found several pathologies that were contributing to her symptoms.
Initial Testing
FIGURE 1: Comprehensive Stool Analysis. Dysbiotic flora are highlighted in red. Commensal flora, which may be
imbalanced, are highlighted in yellow.
Michelle’s stool test found low levels of Lactobacillus and E. coli, both important species of beneficial bacteria.
In addition, it found a 3+ for two species of pathogenic bacteria, Enterobacter cloacae and Klebsiella
pneumoniae. She was negative for yeast.
The Klebsiella is of particular concern given her symptoms. Klebsiella species are associated with conditions
that are characterized by joint pain, including ankylosing spondylitis, reactive arthritis, and rheumatoid
arthritis. It has also been reported in irritable bowel syndrome (which this patient would likely meet the
diagnostic criteria for) and other digestive conditions such as Crohn’s disease. The association between
Klebsiella and autoimmune disease appears to be mediated—at least in some cases—by the HLA-B27 protein,
1 which is found on the surface of white blood cells.
I tested Michelle for HLA-B27 and she was positive. This finding suggests that she may be more susceptible to
autoimmune conditions, and a Klebsiella infection might be more problematic for her than for others who are
HLA-B27 negative.
FIGURE 2: HLA-B27 Blood Test.
FIGURE 3: Small Intestinal Bacterial Overgrowth Test Results.
Her SIBO breath test results indicated methane overproduction. This suggested bacterial overgrowth in the
small intestine, which was likely contributing to her constipation.
FIGURE 4: Urinary Organix (Organic Acids) from Genova Diagnostics.
Her urine organic acids test confirmed the microbial overgrowth and imbalance in her gut, and revealed
several other issues including:
■ B vitamin deficiency. SIBO and a microbial imbalance decrease the absorption of several nutrients,
including B vitamins.
■ Oxidative stress
■ Impaired carbohydrate metabolism
■ Impaired fatty acid metabolism
■ Impaired detoxification capacity
Her routine blood test was mostly unremarkable, with the following exceptions. She had several markers of
iron overload, including ferritin and UIBC that were out of the reference range, and iron saturation that was
out of the functional/optimal range (<45%). Michelle had excessive iron storage but not frank
hemochromatosis. Many people don’t meet the diagnostic criteria for hemochromatosis. The iron elevation
also wasn’t an artifact of inflammation (inflammation alone can cause high ferritin levels) because her iron
saturation and UIBC were abnormal in addition to ferritin. High iron levels have been shown to contribute to
joint pain, cognitive dysfunction, and many other symptoms.
Her TSH and thyroid antibodies were normal, but her free T3 (triiodothyronine, free) was low at 1.7 (range:
2.0–4.4 pg/mL). This was likely contributing to her cold hands and feet, constipation, and brain fog. She also
had a low white blood cell count, which is often observed in autoimmune conditions.
FIGURE 5: Routine Laboratory Tests Including Thyroid Function Markers, Iron, and Vitamin D.
In this case, her low free T3 may be secondary to her gut dysfunction. Approximately 20 percent of T4 is
converted into T3 in the gut. Inflammation—which she is clearly experiencing—also reduces the conversion
of T4 to T3.
FIGURE 6: Analysis of HPA-axis Function Using the Dried Urine Test Comprehensive Hormones (DUTCH) from
Precision Analytical.
Finally, Michelle’s urine hormones revealed high-normal free cortisol but low metabolized cortisol during a
24-hour period. In addition, her diurnal free cortisol production was disrupted, with high levels at night,
high-normal levels upon rising and in the morning, and low levels in the afternoon. Elevated cortisol levels
might have reflected her stress response, consistent with her history of job loss and the death of her mother.
Hypothyroidism impairs the body’s ability to metabolize cortisol, so this pattern of high free cortisol but low
total metabolized cortisol suggested that Michelle had poor thyroid function, which was consistent with her
low free T3.
Treatment
One of the core principles in functional medicine is to address the underlying cause of illness, rather than just
suppressing symptoms. I chose to address her GI issues (the SIBO, dysbiosis, and Klebsiella/HLA-B27) and
then re-test her thyroid markers before taking any specific action for the thyroid dysfunction, because I
believed that it would resolve on its own once her gut function improved and inflammation decreased.
The primary goals of the treatment protocol were:
■ Reduce overgrowth of Klebsiella and prevent further immune attack against HLA-B27 proteins
■ Reduce levels of methanogenic microbes in the small intestine by treating SIBO
■ Restore nutrient balance and metabolic function by improving digestive absorption of nutrients
■ Increase levels of beneficial bacteria and restore a healthy microbial balance in her intestine
■ Bring her iron levels back into a normal range
■ Increase her free T3 levels and improve her thyroid function indirectly by addressing her GI health
■ Normalize her free and total cortisol levels indirectly by addressing her GI health
For Klebsiella, SIBO, and microbial overgrowth, I used a protocol of antimicrobial botanicals, soil-based
and transient commensal probiotics with specific antimicrobial effects, a biofilm disruptor, and a potent
extract of lauric acid (an antimicrobial fatty acid). For iron reduction, I suggested a course of phlebotomy
(via blood donation) until her ferritin was <100 ng/mL and her iron saturation was <40 percent. To help
with her inflammatory symptoms and balance and regulate her immune function, I prescribed a liposomal
form of curcumin.
TABLE 1: Michelle’s Treatment Protocol with Dosages.
TREATMENT NUTRACEUTICAL BRAND DOSAGE

1 packet BID (with breakfast
Antimicrobial GI Synergy Apex Energetics
and dinner)
3-4 capsules BID on an empty
Antimicrobial Interfase Plus Klaire Labs
stomach
One BID upon rising and before
Probiotic Prescript-Assist Prescript-Assist
bed
Probiotic/anti-
MegaSporeBiotic MegaSporeBiotic One capsule with lunch
microbial
Probiotic Ideal Bowel Support Jarrow Formulas L. plantarum for methanogens
Med-Chem 1 scoop three times daily with
Antimicrobial Lauricidin
Laboratories meals
3 billion CFU twice daily at
Probiotic Saccharomycin DF Xymogen
lunch and before bed
One capsule three times a day on
an empty stomach for seven
Anti-inflammatory Optimized Curcumin ProHealth
days, then decrease to one
capsule daily.
After the antimicrobial protocol was completed, I prescribed a combination of fermented foods, fermentable
dietary fibers, probiotics, and prebiotics to restore a healthy gut ecosystem.
Follow-up Testing and Clinical Outcome
FIGURE 7: Comprehensive Stool Analysis Follow-Up.
Michelle received treatment for 60 days and then I ran another set of tests to check on her progress. Michelle’s
follow-up test results indicated a significant improvement. As you can see from her stool test, the Klebsiella
and Enterobacter (dysbiotic flora) were gone. Her beneficial bacteria improved, with the exception of
Lactobacillus, which still needed attention.
She had a 3+ for Saccharomyces boulardii, which is marked as “dysbiotic flora” and a moderate (Mod) level of
yeast in the microscopic section. At first glance this might suggest fungal overgrowth. However, one of the
probiotics I treated her with was Saccharomyces boulardii, so this result is simply showing the presence of that
in her stool. It is not a pathological finding.
FIGURE 8: Follow-up Test Results for SIBO.
Her follow-up SIBO results were normal.
Her organic acids urine test also improved significantly, with only two markers in the low-normal range. This
shows that treating the gut effectively supplied Michelle with critical nutrients (especially B vitamins) that
improved her metabolism.
FIGURE 9: Urinary Organic Acids Follow-up Test.
Her iron saturation dropped to 28 percent after two blood donations. Her ferritin returned to the reference
range, but it remained high normal. Further blood donations would be indicated provided that hemoglobin
and iron saturation do not drop too low.
FIGURE 10: Follow-up Results for Routine Laboratory Testing, Including Thyroid and Iron Markers.
Her free T3 improved dramatically without any specific focus on her thyroid, supporting the functional
medicine principle of addressing the underlying cause. That said, both her TSH and reverse T3 are high-normal,
which may suggest an ongoing thyroid issue or chronic stressor that is not influenced by her GI function. This
would not be surprising given her family history of thyroid disease and her recent stressful experiences.
Finally, her DUTCH test results normalized. Her free cortisol decreased to 111 (range: 80–180) her
metabolized cortisol increased to 2,779 (range: 2240–4300), and her diurnal cortisol rhythm improved. This
also illustrates the importance of addressing the deepest cause(s) of the signs and symptoms you observe first
in the treatment process.
FIGURE 11: Follow-up Results for DUTCH Test
Most importantly, Michelle’s symptoms improved dramatically. Her joint pain was reduced by 80 to 90
percent, and she no longer needed ibuprofen or any other OTC pain medication to manage it.
Her body temperature normalized and she no longer had cold hands and feet. Her constipation, which had
been present for over a decade, resolved—as did her gas and bloating. She was able to think more clearly and
concentrate for longer periods, and she no longer felt anxious. For the first time in many years she was
sleeping deeply through the night and waking up in the mornings feeling refreshed and energized.
Discussion
Michelle presented with joint pain, gut dysfunction, and cognitive and thyroid symptoms. Gastrointestinal
testing revealed a Klebsiella pneumoniae overgrowth, and genetic testing showed that she was positive for HLA-
B27, indicating susceptibility to autoimmunity.
The association between Klebsiella and autoimmune disease appears to be mediated—at least in some cases—
by the HLA-B27 protein,1 which is found on the surface of white blood cells. HLA-B27 is encoded by the B
locus in the major histocompatibility complex (MHC) on chromosome 6 and presents antigenic peptides
(derived from self and non-self antigens) to T cells.
The genetic prevalence of HLA-B27 varies significantly according to ethnicity, ranging from as low as 0.1
percent in people of Japanese descent to 24 percent of people in Northern Scandanavia.
Ninety-two percent of Caucasian people with ankylosing spondylitis (AS) have HLA-B27, but only a small
percentage of people with HLA-B27 will go on to develop AS, rheumatoid arthritis, Crohn’s disease, or other
autoimmune conditions.1 This suggests that an environmental factor must be driving the connection observed
between HLA-B27 and these diseases.
Recent research suggests that Klebsiella may be this factor. Dr. Alan Ebringer at Middlesex Hospital in London
found that Klebsiella has molecules resembling the HLA-B27 blood group.2,3 Although Klebsiella is a normal
resident of the digestive tract, it can overgrow when the gut microbiota is disrupted or out of balance.
Elevated levels of antibodies to Klebsiella have been found in AS patients, especially during flare-ups.
Researchers speculate that the body produces antibodies to attack the Klebsiella bacteria, but these antibodies
also act upon HLA-B27 proteins in a phenomenon known as “molecular mimicry.”1 The destruction of the
HLA-B27 proteins is what causes the joint pain3 and inflammation that characterizes rheumatic diseases like
AS and rheumatoid arthritis, as well as Crohn’s disease.
Michelle’s urine hormone test results showed that she had trouble metabolizing cortisol, which is a sign of
hypothyroidism. Again, cortisol and thyroid markers were not addressed directly in this case. Instead,
restoring gut function normalized cortisol patterns and thyroid function.
Michelle’s case illustrates why I prefer DUTCH testing to saliva testing for cortisol and HPA axis assessment.
Thyroid hormone is required for the metabolic clearance of cortisol. Patients with hypothyroidism or low T3
levels will have trouble metabolizing cortisol. They often present with high free cortisol but low cortisol
metabolites in the urine. In fact, the ratios between free and metabolized cortisol as well as cortisol and
cortisone are being investigated as markers of subclinical thyroid hypofunction.4
If you only did a saliva test on this patient for cortisol, you’d assume that her cortisol was high (because of the
high free cortisol). However, metabolized cortisol is a better marker for overall production. Less than 5
percent of the cortisol in the body is in the free (unbound) form; the rest is cleared by several metabolic
pathways and excreted in the urine.
If you gave this patient supplements to lower cortisol levels, as indicated by the saliva test results, she would
probably get worse. Her metabolized cortisol was low. Cortisol is a potent anti-inflammatory hormone, and
her low levels could be one of the driving factors behind her joint pain and other inflammatory symptoms.
At the same time, giving her supplements to increase cortisol might also have an adverse effect. She already
had high free cortisol levels, and free cortisol is the most potent form of that hormone. In this case, the best
strategy was once again to address the underlying cause of the dysfunction, which was the poor thyroid
function. But as mentioned earlier, the poor thyroid function was itself likely a “symptom” of a deeper
problem: the disrupted gut microbiota and microbial overgrowth. A successful and focused functional
medicine diagnosis and treatment is sometimes like peeling an onion!
Metabolic testing (organic acids) showed that she had widespread nutrient insufficiencies. By treating the gut
alone, her nutrient status improved. It is safe to assume that she was able to digest and assimilate nutrients
better once we resolved her gut dysbiosis.
Michelle showed high iron markers, suggesting iron overload, even though she did not meet the strict diagnostic
criteria for hemochromatosis.5 There are many potential causes of iron overload, many of which are still poorly
understood. Also, studies have shown that even people who are heterozygous for HFE (human hemochromatosis
protein) gene mutations can have higher than normal levels of iron. Because high iron levels can cause
symptoms, phlebotomy treatments to lower her iron likely contributed to her improved sense of wellbeing.
Addressing Michelle’s GI health had far-reaching consequences: it reduced joint inflammation, improved
nutrient status, and normalized cortisol and thyroid markers. Clinically, her improvement was dramatic. She
no longer complained of joint pain, hypothyroid symptoms, gut symptoms, or cognitive problems.
References
1. Brent LH, Diamond HS. Ankylosing spondylitis and undifferentiated spondyloarthropathy. Drugs & Diseases 2015;
http://emedicine.medscape.com/article/332945-overview. Accessed May 14, 2015.
2. Ebringer A, Wilson C. HLA molecules, bacteria and autoimmunity. Journal of medical microbiology. 2000;49(4):
305-311.
3. Rashid T, Ebringer A. Gut-mediated and HLA-B27-associated arthritis: an emphasis on ankylosing spondylitis and
Crohn's disease with a proposal for the use of new treatment. Discovery medicine. 2011;12(64):187-194.
4. Vantyghem MC, Ghulam A, Hober C, et al. Urinary cortisol metabolites in the assessment of peripheral thyroid
hormone action: overt and subclinical hypothyroidism. J Endocrinol Invest. 1998;21(4):219-225.
5. Makker J, Hanif A, Bajantri B, Chilimuri S. Dysmetabolic hyperferritinemia: all iron overload is not
hemochromatosis. Case reports in gastroenterology. 2015;9(1):7-14.
iiiiiiiiiiiiiiiiiiiiiiiiii
iii
iii
iii
iii
Diabetes and Other Blood Sugar
Disorders Case Study
Restored Blood Sugar Control in a Diabetic Woman with
Gastrointestinal Complaints and Nutritional Deficiencies
CASE SUMMARY
Chandra, a 66-year-old woman with type 2 diabetes and gastrointestinal complaints, experienced a wake-
up call when her mother died of diabetes-related complications. Chandra had a poor diet and a sedentary
lifestyle and complained of abdominal pain, nausea, vomiting, bloating, decreased appetite, and
heartburn. Testing confirmed her high blood sugar and hemoglobin A1c (HbA1c). It also revealed
systemic inflammation, low vitamin D and vitamin B12, and disrupted cortisol patterns. There was
evidence of autoimmune attack of thyroid proteins and intrinsic factor. Her stool test showed bacterial
and fungal overgrowth, Helicobacter pylori, and a significant inflammatory and immune response in the
gut. The treatment protocol included a Paleo diet, physical activity, supplementation to increase vitamin
B12 and vitamin D, and treatment for gastrointestinal (GI) dysbiosis. Finally, there were supplement and
lifestyle interventions to balance thyroid function, HPA axis, and blood sugar. Over the course of
treatment, Chandra had an 80 percent improvement in her GI symptoms; she lost 19 pounds; and she
reported much better energy. Her fasting blood glucose went from 156 mg/dL to 90 mg/dL and
hemoglobin A1c went from 8.0% to 5.8%. This case demonstrates that the progression of diabetes can be
prevented with careful attention to diet, physical activity, hormonal balance, gut health, and nutrition.
Initial Presentation and Lab Testing

Chandra, a 66-year old female, came to see me with the following concerns: abdominal pain with nausea and
vomiting at night, bloating, decreased appetite, heartburn, and type 2 diabetes.
She worked as a software engineer and spent about eight to 10 hours a day sitting in front of a computer. She did
not exercise other than an occasional walk with friends on the weekend. Her diet was poor and she rarely cooked
her own food. Breakfast was usually coffee and a muffin in the car on the way to work. For lunch, she grabbed
something quick from the company cafeteria or a local restaurant and ate quickly at her desk. For dinner she
would get take-out from a local restaurant most nights during the week and go out to eat on the weekends.
Chandra had a family history of type 2 diabetes and had been diagnosed herself nearly 10 years before she
came to see me. However, she had a strong mistrust of conventional Western medicine and chose not to take
the medications that were prescribed by her primary care physician. She intermittently took Ayurvedic herbs,
which she was more comfortable with, but they failed to bring her blood sugar down to normal levels.
Although she was not following a diet when she came to see me, she had previously made several attempts to
follow the low-fat, high-carbohydrate diet recommended by organizations like the American Diabetes
Association (ADA). She reported difficulty sticking with this approach: She always felt hungry, gained weight,
and experienced a worsening of her blood sugar.
Chandra’s mother had passed away six months prior to our appointment, largely from complications related
to type 2 diabetes. This served as a wake-up call for Chandra, and she felt more motivated to address the root
causes of her condition, including making the necessary dietary and lifestyle changes.
Chandra’s poor diet and sedentary lifestyle were obviously contributing to her high blood sugar. I ran a full
panel of laboratory tests to identify any other underlying conditions that may have been provoking metabolic
dysfunction, as well as digestive distress.
TABLE 1A: Routine Laboratory Test Results. Includes standard laboratory ranges and functional (or optimum)
ranges. Results highlighted in yellow are outside of the functional ranges. Results highlighted in red are outside of the
standard lab ranges. Results in orange are outside of the functional range and the laboratory range.
TABLE 1B: Routine Laboratory Test Results, continued.
As expected, Chandra’s fasting glucose (156 mg/dL) and hemoglobin A1c (8.0%) were in the diabetic range.
Surprisingly, her triglycerides and HDL were within the laboratory reference range, although they were
slightly outside of the functional (optimal) range. Other notable findings included:
■ Depressed BUN/creatinine ratio. This is often caused by low muscle mass, which in Chandra’s case was a
result of her sedentary lifestyle.
■ Borderline high LDH. Lactate dehydrogenase (LDH) is an enzyme that is elevated in a variety of
conditions, including liver disease, kidney disease, and pernicious anemia (which was the likely cause in
Chandra’s case, as you’ll see below).
■ Low serum B12. This is more common in people following vegetarian or vegan diets, but does still occur
in omnivores—especially those with gastrointestinal issues or pernicious anemia.
■ Extremely low 25(OH)D. Chandra had one of the lowest vitamin D levels I have ever observed.
■ Moderately elevated total and LDL cholesterol. Chandra’s slightly elevated total and LDL cholesterol
would not concern me on their own, but given her multiple markers of metabolic dysfunction, further
investigation was warranted.
■ Borderline high hs-CRP. High-sensitivity C-reactive protein is a marker of systemic inflammation that is
consistently associated with type 2 diabetes and other metabolic diseases.1
■ Elevated homocysteine. Homocysteine is a sticky, inflammatory protein associated with metabolic and
cardiovascular disease.
■ Elevated TSH, with borderline low T4 and T3. A high thyroid-stimulating hormone (TSH) level is the
most sensitive indicator of hypothyroidism. Chandra’s T4 and T3 levels were within the lab reference
range, but below the functional range.
■ Borderline low zinc-copper ratio. The zinc-copper ratio is best understood as a marker of inflammation,
rather than as a marker of nutritional status of either element.2
■ Borderline low hemoglobin and hematocrit. This likely signals the early stages of megaloblastic anemia
caused by B12 deficiency.
Based on these initial findings, I ordered additional blood tests, including a more complete thyroid panel with
free T4, free T3, and thyroid antibodies (to determine if Chandra had Hashimoto’s), post-meal blood sugar
testing with a glucometer, and a comprehensive metabolic panel.
FIGURE 1: Thyroid Function Markers and Thyroid Antibodies.
The thyroid panel revealed low levels of free T3, the most active form of thyroid hormone. They also found
elevated thyroglobulin antibodies, which are indicative of Hashimoto’s thyroiditis.
FIGURE 2A: The MetSyn Profile from Genova Diagnostics measures glucose, HbA1c, lipids, inflammation,
and metabolism.
FIGURE 2B: MetSyn Profile, continued.
The MetSyn profile from Genova Diagnostics has a number of markers for diabetes and metabolic
dysfunction. Chandra had elevated LDL particle number, small LDL particle number, insulin, pro-insulin,
homeostasis model assessment-estimated insulin resistance (HOMA-IR), C-peptide, and leptin levels. She also
had elevated inflammatory markers, such as hs-CRP, interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis
factor-alpha (TNF-a), and plasminogen activator inhibitor-1 (PAI-1).
TABLE 2: Glucometer Readings Taken at Home. Blood sugar was measured under fasting conditions, one hour
after eating, or two hours after eating. The suggested ranges are <99 mg/dL fasting, <140 mg/dL one hour after a
meal, and <120 mg/dL two hours after a meal. Colors separate days with multiple readings.
HIGH
HIGH
HIGH
HIGH
NORMAL/BORDERLINE HIGH
NORMAL
NORMAL
I asked Chandra to use a glucometer to test her blood sugar over several weeks, both before and after meals.
Post-meal blood sugar is considered to be a more sensitive predictor of type 2 diabetes progression. The
suggested cutoffs are <99 mg/dL fasting, <140 mg/dL one hour after a meal, and <120 mg/dL two hours after
a meal. As you can see, both her fasting and post-meal glucose readings were consistently elevated, though on
a relative basis, her fasting glucose is higher than her post-meal glucose.
FIGURE 3: Organix Comprehensive Profile from Genova Diagnostics measures urinary markers of B vitamins.
Chandra’s urine organic acids test revealed elevated levels of methylmalonic acid (MMA). The conversion of
succinic acid to methylmalonic acid requires methylcobalamin, an active form of B12. High levels of MMA
suggest active B12 deficiency, which supports the finding of low B12 in Chandra’s blood work.
FIGURE 4: Intrinsic Factor Antibody Test.

RESULT REFERENCE RANGE
Given that Chandra ate meat regularly but still had low B12 levels, I decided to screen her for pernicious anemia.
Pernicious anemia is an autoimmune condition in which the body attacks either the parietal cells, which produce
intrinsic factor; intrinsic factor itself; or both. Intrinsic factor is required to absorb B12 from diet or oral
supplements, so patients with pernicious anemia will become B12 deficient even if they are eating sufficient
amounts of B12 or taking typical oral forms of B12. Chandra was positive for antibodies to intrinsic factor.
FIGURE 5A: Comprehensive Stool Analysis from Doctor’s Data. Dysbiotic flora are highlighted in red. Commensal
flora, which may be imbalanced, are highlighted in yellow.
FIGURE 5B: Comprehensive Stool Analysis with Helicobacter pylori stool antigen.
FIGURE 5C: Comprehensive Stool Analysis, continued.
Chandra’s stool test revealed low levels of beneficial E. coli, Enterococcus, and Lactobacillus, high levels of
imbalanced flora such as alpha- and gamma-hemolytic streptococcus. Chandra had dysbiosis. She showed high
levels of the pathogenic bacterium Citrobacter freundii (Figure 5a). She also had significant fungal overgrowth (as
seen under the microscope) in all three stool samples and tested positive for H. pylori (Figure 5b).
Chandra wasn’t digesting or absorbing her food properly. Chandra’s fecal elastase level was low, and she tested
positive for carbohydrate malabsorption (Figure 5c).
Finally, Chandra’s lysozyme and secretory IgA levels were elevated, indicating inflammation and immune
activation in the gut. This was most likely due to her significant dysbiosis and fungal overgrowth.
FIGURE 6: Small Intestinal Bacterial Overgrowth Breath Test Results.
Chandra’s breath test results showed a classic “double peak” of both hydrogen and methane, which strongly
suggested small intestine bacterial overgrowth (SIBO).
FIGURE 6: Analysis of Hypothalamic–Pituitary–Adrenal Axis Function Using the Dried Urine Test
Comprehensive Hormones (DUTCH) from Precision Analytical
Chandra’s DUTCH hormone profile revealed high levels of metabolized cortisol, free cortisone, and free
cortisol. Her daily free cortisol and cortisone patterns were abnormal, suggesting a disrupted diurnal cortisol
rhythm. She had an elevated cortisone-to-cortisol ratio. All of these findings are consistent with type 2
diabetes and metabolic dysfunction (see Discussion).
Initial Treatment Plan

Given all of these findings, we had a lot of work to do after the initial appointment! In a situation like this,
starting with diet and lifestyle change is the most important intervention you can do, since it is likely the root
cause of many if not most of the patient’s pathologies.
I suggested that Chandra follow a Paleo Reset Diet for 60 days, without lowering her carbohydrate intake (see
Discussion). I also suggested that Chandra increase her physical activity. Since she was almost completely
sedentary, I recommended a gentle ramp-up including walking 5,000 steps a day (which she used a FitBit to
track) and two to three days of strength training at the gym to increase her muscle mass and fat-burning
capacity. Later, as her exercise tolerance improved, I would suggest adding some high-intensity interval
training to further increase her fat-burning capacity.
In addition to the diet and lifestyle changes, we needed to address Chandra’s pernicious anemia, Hashimoto’s
hypothyroidism, dysbiosis and fungal overgrowth, H. pylori, gut inflammation, SIBO, and disrupted HPA
axis. If we tried to do this all at once, Chandra would have been taking 20-plus supplements and almost
certainly would have been overwhelmed. Part of the “art” of functional medicine is figuring out how to layer
and structure a treatment with complex, multifactorial presentations like this.
We began by addressing her gut, B12 and vitamin D deficiency, and HPA axis. Digestive symptoms were her
primary reason for coming to see me, and it’s important to address the patient’s chief complaint or they will
not stick around for long! Moreover, a large body of evidence suggests a strong association between a
disrupted gut microbiome and both metabolic and thyroid dysfunction. B12 deficiency can have potentially
irreversible neurological consequences if not addressed, and given that Chandra was already 66 years old, I
wanted to restore normal B12 levels as soon as possible. I also knew that B12 deficiency causes fatigue, so
she’d be more likely to follow through on her physical activity prescription once I corrected her B12
deficiency. Finally, high cortisol can contribute to hyperglycemia, poor thyroid function, and gut imbalances,
so I felt it was important to address this in the initial phase of the treatment plan.
For her gut, I used a botanical antimicrobial protocol that included GI Synergy, Lauricidin, InterFase Plus,
Prescript-Assist, Saccharomyces boulardii, and A-FNG to treat the SIBO, dysbiosis, and fungal overgrowth. For
the H. pylori, I added Jarrow BroccoMax (one capsule three times a day with meals) and 500 mL per day of
100% cranberry juice, unsweetened.3,4
TABLE 3: Chandra’s Treatment Protocol with Dosages.

One BID upon rising and
before bed
3 billion CFU twice daily
Probiotic Saccharomycin DF Xymogen at lunch and before
bed
1 packet BID (with
breakfast and dinner)
1 scoop three times daily
Antimicrobial Lauricidin Med-Chem Laboratories
with meals
Slowly build to 20-30
Antimicrobial A-FNG Byron White Formulas
drops BID with meals
3-4 capsules BID on an
Antimicrobial InterFase Plus Klaire Labs
empty stomach
Microbial balance BroccoMax Jarrow Formulas 1 capsule TID with meals
Cranberry juice,
Microbial balance 500 mL/day
unsweetened
Nutrition Extra Virgin Cod Liver Oil Rosita Real Foods 1 tsp/day
Nutrition Trifolamin Designs for Health 1 lozenge (5 mg)/day
Nutrition Micellized Vitamin D3 Klaire Labs 10,000 IU/day
2 caps twice daily with

HPA-axis support HPA Balance Vital Plan
food
1 cap three times daily
HPA-axis support Acetyl-CH Apex Energetics
with food
For B12 deficiency, I used Trifolamin from Designs for Health. Trifolamin provides a synergistic combination
of the three bioavailable forms of B12: methylcobalamin, adenosylcobalamin, and hydroxycobalamin, in a five
mg sublingual lozenge. Sublingual delivery is crucial for patients with pernicious anemia because their
intestinal absorption of B12 from diet or oral supplements is limited. I had Chandra take one lozenge per day
and instructed her to continue this indefinitely.
For vitamin D, I prescribed one tsp/d of Extra Virgin Cod Liver Oil (to provide whole-food forms of both
vitamin D and vitamin A, which work synergistically together), along with 10,000 IU of Micellized Vitamin
D3 from Klaire Labs. I did not think that cod liver oil alone would be sufficient to raise her vitamin D
quickly, and I prescribed a micellized form of D3 because Chandra had several gut conditions that could lead
to malabsorption.
For her HPA axis, I prescribed a number of behavioral and lifestyle modifications, including restricting
exposure to artificial light at night and ensuring at least 20 to 30 minutes of bright light exposure during the
day (which she accomplished by taking a walk for half of her lunch hour), getting at least eight hours of sleep
a night, and practicing mindfulness-based stress reduction at least three times a week. I also prescribed
supplements to regulate her diurnal cortisol rhythm and reduce her cortisol, including HPA Balance from
Vital Plan (two capsules twice a day, with breakfast and dinner) and Acetyl-CH Active from Apex Energetics
(one capsule three times a day, with meals).
Sixty-Day Follow-up: Clinical Outcome and Additional Testing

After 60 days of this protocol, Chandra’s digestive symptoms were 80 percent resolved, her energy levels
improved significantly, she lost 19 pounds, and her blood sugar had dropped from the diabetic range to the
pre-diabetic range. Her follow-up tests results also showed significant improvements across the board.
FIGURE 8: Follow-up Thyroid Function Markers, Iron, and Vitamins D and B12.
Her free T3 levels were now well within the normal range. Inflammation and poor gut health reduce the
conversion of T4 to T3, so it is likely that the dietary and lifestyle changes Chandra made improved her
thyroid function. This is why I often do not address thyroid directly in the first step of the treatment in
situations like this. Her vitamin D upon follow-up was firmly within the normal range, as was her serum
vitamin B12. 
FIGURE 9: Urinary Organic Acid Markers Show Adequate Vitamin B12 Levels after 60 Days of Treatment.
Her urine methylmalonate normalized, indicating that she had sufficient levels of active vitamin B12.
FIGURE 10A: Comprehensive Stool Analysis Results after 60 Days of Treatment.
FIGURE 10B: Comprehensive Stool Analysis Results after 60 Days of Treatment, continued.
FIGURE 10C: Comprehensive Stool Analysis Results after 60 Days of Treatment, continued.
Chandra’s follow-up stool test showed much-improved levels of beneficial bacteria and eradication of
Citrobacter freundii and fungal overgrowth. Previously, her stool test showed many fungal cells under the
microscope for all three stool samples. In this test, no fungal cells were seen for any of the samples. The
Candida parapsilosis at 1+ growth did not strike me as a clinically relevant issue for her. Her follow-up stool
antigen test for H. pylori was negative, indicating that the infection had been cleared.
Chandra’s digestion improved. Her elastase and carbohydrate absorption markers normalized. Her gut
inflammation decreased: Both lysozyme and sIgA decreased significantly. This suggests that her immune
reactivity normalized, most likely because Citrobacter, fungus, and H. pylori had been removed. At the time of
this writing, there were no follow-up results on Chandra’s systemic inflammatory markers. But considering
that dysbiosis and inflammation decreased in the gut, systemic markers of inflammation could have easily
improved. Her sIgA was low on this test, whereas it was high on the initial test. This is not uncommon, in my
experience, and sIgA is often one of the last markers to improve when addressing gut health.
FIGURE 11: Follow-up SIBO Test Results
Her SIBO breath test results were normal after 60 days of treatment. Her hydrogen and methane breath gases
normalized, suggesting that bacterial overgrowth in the small intestine was no longer an issue for Chandra. 
FIGURE 12: Follow-up Results for HPA Axis Function using the DUTCH Test.
Her DUTCH hormone profile revealed completely normal cortisol production. Frankly, I was quite surprised
by this, as it often takes much longer to address HPA axis dysfunction, especially if it is a primary cause of
symptoms. It is possible that Chandra’s mother’s death caused an unusual spike in her cortisol levels on her
initial DUTCH test (Figure 7) that naturally normalized as time passed. It is also possible that interventions
to normalize sleep patterns, remove gut infections, reduce body weight, and increase physical activity had a
significant impact on Chandra’s HPA axis function.
Treatment Plan Modifications Made after 60 Days

Even after 60 days of treatment, Chandra’s TSH was still elevated. I felt that her thyroid needed additional
support at that point. I prescribed a desiccated thyroid glandular supplement (from Nutri-Meds) because
Chandra preferred not to take pharmaceuticals. Antimicrobials were discontinued at this time but other
interventions continued, including HPA axis support and dietary changes.
120-Day Follow-up: Clinical Outcome and Additional Testing

After 60 days on the desiccated thyroid, we re-tested Chandra’s thyroid numbers again, and they were normal.
I also re-tested her blood sugar. After 120 days of overall treatment, Chandra’s fasting glucose and HbA1c
were still elevated, but they were significantly improved. Her results were toward the bottom of the pre-
diabetic range, rather than well within the diabetic range.
FIGURE 13: Follow-up Results for Thyroid Markers after 120 Days of Treatment.
FIGURE 14: Chandra’s Glucose and HbA1c after 120 Days of Treatment.
Ideally, I’d like to get Chandra’s blood sugar levels into the normal ranges. However, not all cases of diabetes
can be reversed with natural interventions. In cases where type 2 diabetes has been present for many years and
beta cell destruction may have occurred, it may not be completely reversible with diet and lifestyle changes
and supplementation alone. This is particularly true if leptin and insulin are as elevated as they were for
Chandra on her initial test (Figure 2b). The drug metformin may be a good option to further improve glucose
control in cases like Chandra’s, though the potential benefits of the small reduction in fasting glucose and A1c
that we’d be likely to observe would have to be weighed against the side effects and risks of the medication.
Treatment Plan Modifications after 120 Days

Nutraceuticals are another option for further reduction of blood sugar in cases like this. I prescribed two
supplements: Metabolic Synergy (two capsules three times a day with meals) and GlucoSupreme (two capsules
twice a day with meals) from Designs for Health. These products contain a number of nutrients and botanicals
that support blood sugar regulation. No other changes were made to the treatment protocol at this time.
FIGURE 15: One Hundred Eighty-Day Follow-up Testing: Blood Glucose Regulation.
After an additional 60 days on these supplements (amounting to 180 days total of treatment), Chandra had
a fasting glucose <100 mg/dL for the first time in 10 years. Her HbA1c was still elevated, as were some of
her post-meal glucose levels. However, this is a remarkable improvement using only diet and lifestyle
changes and supplements.
Discussion
Chandra was a 66-year-old untreated diabetic woman with significant gastrointestinal symptoms and poor
dietary and lifestyle habits. Chandra had marked improvement of GI symptoms, energy, and blood sugar after
six months of a Paleo diet, normalization of HPA axis function, nutritional supplementation for pernicious
anemia and vitamin D, treatment for GI dysbiosis and inflammation, and supplements to support thyroid
function and blood sugar regulation.
Dietary Recommendations
I suggested that Chandra follow a Paleo Reset Diet for 60 days. Numerous studies have shown that Paleo is
effective for reducing blood sugar and improving inflammatory markers and that it is more satiating per
calorie than Mediterranean or low-fat diets, which makes it easier for patients to follow.5 ,6
I did not specifically instruct Chandra to lower her carbohydrate intake for two reasons. First, the Paleo diet
studies that showed significant improvement in metabolic function were not very-low-carb diets; they
typically ranged between 20 and 30 percent of calories from carbohydrate. I believe that carbohydrate quality
(e.g., eating whole-food, unrefined carbohydrates rather than highly refined carbohydrates) is more important
than carbohydrate quantity in most cases, and if significant weight loss and metabolic improvement is possible
without severely restricting an entire macronutrient category, that is preferable from a general health and
compliance perspective. Second, most patients that follow a Paleo diet naturally eat fewer carbohydrates, since
their choices of carbohydrate are limited to starchy plants like sweet potatoes and fruits.
Nutrition
Vitamin D
Chandra had one of the lowest vitamin D levels I have ever observed—8.3 ng/mL (Table 1a). I recommend
vitamin D serum levels of 25–50 ng/mL. Chandra spent very little time outdoors and did not take a vitamin
D supplement. She was of East Indian descent and had relatively dark skin, which means she produced less
25(OH)D in response to sun exposure than people with lighter skin. Low levels of vitamin D are associated
with metabolic dysfunction in numerous studies. 7
Vitamin B12 and Pernicious Anemia

Chandra had very low levels of vitamin B12, high urinary methylmalonate (Figure 3), very high
homocysteine, low hemoglobin, and low hematocrit. Homocysteine is a sticky, inflammatory protein
associated with metabolic and cardiovascular disease (Table 1a). Vitamin B12 and folate are required to
convert homocysteine back into methionine in the methylation cycle; thus, Chandra’s B12 deficiency was the
likely cause of her high homocysteine level.
Given that Chandra ate meat regularly but still had low B12 levels, I decided to screen her for pernicious
anemia. Pernicious anemia is an autoimmune condition in which the body attacks either the parietal cells,
which produce intrinsic factor; intrinsic factor itself; or both. Intrinsic factor is required to absorb B12 from
diet or oral supplements, so patients with pernicious anemia will become B12 deficient even if they are eating
sufficient amounts of B12 or taking typical oral forms of B12. Chandra was positive for antibodies to intrinsic
factor (Figure 4). This test approaches 100 percent specificity, which means that if it is positive, it is almost
certain that the patient has pernicious anemia. (Note that although intrinsic factor antibodies are highly
specific, they are only 50 to 70 percent sensitive. This means that 30 to 50 percent of patients with pernicious
anemia will not have antibodies to intrinsic factor.)8
Borderline low hemoglobin and hematocrit (Table 1b) likely pointed to the early stages of pernicious anemia
caused by B12 deficiency. B12 deficiency progresses in four stages, and it is only in the final stage that the
patient becomes anemic. This is one of many reasons that it is important to test B12 levels on a routine blood
panel. Unfortunately, this is rarely done in conventional medicine. Chandra had no idea that she was B12
deficient and had pernicious anemia prior to her appointment with me, and she was 66 years old!9
HPA Dysfunction and Diabetes

Chandra had high levels of metabolized cortisol, free cortisone, and free cortisol. Her daily free cortisol and
cortisone patterns were abnormal, suggesting a disrupted diurnal cortisol rhythm. She had an elevated
cortisone-to-cortisol ratio. This was consistent with research showing an association between metabolic
dysfunction, high cortisol levels, and excess weight and type 2 diabetes.10,11
Fat tissue can contribute to HPA axis dysfunction. Fat tissue itself releases cortisol.12 , 13 The relationship
between HPA axis function and obesity is bi-directional and most studies have not been able to show a causal
relationship between high free cortisol (HPA axis dysfunction) and obesity. However, studies do show
increased clearance of cortisol (and thus higher cortisol metabolites) with increasing weight.14 There is a
stepwise relationship between urinary cortisol metabolites and body BMI, even at levels that aren’t obese.15 In
addition, the conversion of cortisone to cortisol is impaired in obesity, which leads to a high ratio of cortisone
to cortisol in these patients.16
Thyroid Function
Chandra had high TSH, low-normal T4 and T3 (Table 1b), and low levels of free T3, the most active form of
thyroid hormone (Figure 1). She had elevated thyroglobulin antibodies, which are indicative of Hashimoto’s
thyroiditis. This suggested that Chandra’s thyroid dysfunction was caused by autoimmunity. Some studies
suggest that thyroid autoimmunity may contribute to endothelial dysfunction and other metabolic and
cardiovascular abnormalities.17
Gastrointestinal Health and Diabetes
Chandra had very low fecal pancreatic elastase, suggesting difficulty with digestion (Figure 5c). Studies have
found a strong correlation between low fecal elastase and type 2 diabetes.18 She also had SIBO (Figure 6). One
study found an association between delayed orocecal transit time/SIBO and patients with type 2 diabetes, but
it was unclear whether SIBO contributed to type 2 diabetes, or the other way around.19 Nevertheless, I
frequently see these conditions appear together in clinical practice, and the relationship is likely bi-directional.
Conclusions
Chandra had a strong family predisposition to diabetes that was compounded by a sedentary lifestyle and a
poor diet. She was diabetic and headed down a path of diabetes-related complications and an increased risk of
death. Chandra had significant gastrointestinal symptoms including abdominal pain with nausea and
vomiting, bloating, decreased appetite, and heartburn.
Lab testing showed elevated blood glucose and HbA1c, extremely low vitamin D, inflammation, pernicious
anemia, Hashimoto’s thyroiditis and associated thyroid dysfunction. She had gut dysbiosis including bacterial
and fungal overgrowth and colonization with H. pylori. She wasn’t digesting or absorbing her food and
showed signs of inflammation and immune upregulation in the GI tract. Finally, her cortisol diurnal rhythm
and cortisol metabolism were disturbed.
Treatment primarily focused on diet and physical activity, gut dysbiosis, vitamins B12 and D, HPA axis
function, and thyroid support. After 60 days, Chandra had an 80 percent reduction in her GI symptoms and
had lost 19 pounds. She reported significant energy improvements. After 180 days of treatment, thyroid
function markers had normalized, and her fasting glucose was < 100 mg/dL for the first time in 10 years.
Laboratory markers confirmed that blood glucose was better regulated, vitamin levels improved, gut dysbiosis
resolved, and HPA and thyroid function normalized. This case demonstrates that the course of diabetes and
pre-diabetes can be halted, and even reversed, with careful attention to diet, physical activity, hormonal
balance, gut health, and customized nutrition.
References 
1 Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing
type 2 diabetes mellitus. JAMA. 2001;286(3):327-334.
2 Malavolta M, Giacconi R, Piacenza F, et al. Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as

predictor of all-cause mortality in elderly population. Biogerontology. 2010;11(3):309-319.
3 Fahey JW, Haristoy X, Dolan PM, et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains
of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci U S A. 2002;99(11):
7610-7615.
4 Shmuely H, Domniz N, Yahav J. Non-pharmacological treatment of Helicobacter pylori. World J Gastrointest

Pharmacol Ther. 2016;7(2):171-178.
5 Mellberg C, Sandberg S, Ryberg M, et al. Long-term effects of a Palaeolithic-type diet in obese postmenopausal
women: a 2-year randomized trial. Eur J Clin Nutr. 2014;68(3):350-357.
6 Jonsson T, Granfeldt Y, Erlanson-Albertsson C, Ahren B, Lindeberg S. A paleolithic diet is more satiating per calorie
than a mediterranean-like diet in individuals with ischemic heart disease. Nutrition & metabolism. 2010;7:85.
7 Dhas Y, Mishra N, Banerjee J. Vitamin D Deficiency and Oxidative Stress in Type 2 Diabetic Population of India.
Cardiovasc Hematol Agents Med Chem. 2016.
8 Carmel R. Pepsinogens and other serum markers in pernicious anemia. Am J Clin Pathol. 1988;90(4):442-445.
9 Herbert V. Staging vitamin B-12 (cobalamin) status in vegetarians. Am J Clin Nutr. 1994;59(5 Suppl):1213S-1222S.
10 Costa DS, Conceicao FL, Leite NC, Ferreira MT, Salles GF, Cardoso CR. Prevalence of subclinical hypercortisolism
in type 2 diabetic patients from the Rio de Janeiro Type 2 Diabetes Cohort Study. Journal of diabetes and its complications.
2016.
11 Abraham SB, Rubino D, Sinaii N, Ramsey S, Nieman LK. Cortisol, obesity, and the metabolic syndrome: a cross-
sectional study of obese subjects and review of the literature. Obesity (Silver Spring). 2013;21(1):E105-117.
12 Stimson RH, Andersson J, Andrew R, et al. Cortisol release from adipose tissue by 11beta-hydroxysteroid
dehydrogenase type 1 in humans. Diabetes. 2009;58(1):46-53.
13 Rask E, Walker BR, Soderberg S, et al. Tissue-specific changes in peripheral cortisol metabolism in obese women:
increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab. 2002;87(7):3330-3336.
14 Abraham SB, Rubino D, Sinaii N, Ramsey S, Nieman LK. Cortisol, obesity, and the metabolic syndrome: a cross-
sectional study of obese subjects and review of the literature. Obesity (Silver Spring). 2013;21(1):E105-117.
15 Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH. Cortisol metabolism in human obesity: impaired
cortisone-->cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab. 1999;84(3):1022-1027.
16 Ibid.
17 Isguven P, Gunduz Y, Kilic M. Effects of Thyroid Autoimmunity on Early Atherosclerosis in Euthyroid Girls with
Hashimoto's Thyroiditis. Journal of clinical research in pediatric endocrinology. 2016;8(2):150-156.
18 Kangrga RN, Ignjatovic SD, Dragasevic MM, Jovicic SZ, Majkic-Singh NT. Pancreatic Elastase Levels in Feces As A
Marker of Exocrine Pancreatic Function in Patients With Diabetes Mellitus. Lab Med. 2016;47(2):140-148.
19 Rana S, Bhansali A, Bhadada S, Sharma S, Kaur J, Singh K. Orocecal transit time and small intestinal bacterial
overgrowth in type 2 diabetes patients from North India. Diabetes Technol Ther. 2011;13(11):1115-1120.
Thyroid Disorders Case Study
Hypothyroidism Resolved by Restoring Iodine Levels
CASE SUMMARY
A 26-year-old woman complained of classic hypothyroid symptoms, had been given a hypothyroid
diagnosis, and wanted to investigate natural alternatives to treatment with levothyroxine. Thyroid
function tests, iron, and vitamin D were abnormal. Testing of gastrointestinal health suggested dysbiosis,
especially bacterial overgrowth, and inflammation. She had difficulty metabolizing cortisol, a feature of
hypothyroidism. Her diet was extremely low in iodine and she was eating goitrogenic foods, which
pointed to iodine deficiency. Treatment included kelp tablets, selenium-rich foods, cod liver oil, an
antimicrobial protocol, probiotics, and lifestyle changes and supplements to support HPA axis function.
After three months on this program, her hypothyroid symptoms improved dramatically and her TSH and
other thyroid markers normalized—without any medication at all.
Janel, 26, came to see me after being diagnosed with hypothyroidism. She was overweight, her hands and feet
“felt like icicles,” her hair was falling out, and she was constipated.
Her doctor prescribed levothyroxine, a synthetic thyroid hormone, but Janel wanted to know why her thyroid
wasn’t working properly and whether there was something she could do to address her condition without
resorting to medication.
I ran a thyroid panel (TSH, T3, T4, free T3, free T4), complete blood count (CBC), comprehensive
metabolic panel, and some other blood tests available through standard laboratories such as iron and vitamin
D. Because of her constipation and hypothyroid symptoms, I also ran tests on her gastrointestinal function
using a small intestinal bacterial overgrowth (SIBO) breath test, a stool analysis, and urinary organic acids to
look for dysbiosis. I ordered a panel to look at her hypothalamic-pituitary-adrenal (HPA) axis function and a
urine iodine test.
My panel of initial tests returned the following notable results.
FIGURE 1: Thyroid Function Tests and Complete Blood Count.
Janel’s thyroid-stimulating hormone (TSH) was significantly elevated at 23.77. Her total and free T4 were
well within the normal reference range, but both her total T3 and free T3 were low-normal. Total T3 was 77
ng/dL (range: 71–180) and free T3 was 2.3 pg/mL (range: 2–4.4). These levels are below what I consider to
be optimal (i.e., outside of the functional range). Janel also had low levels of vitamin D and high levels of
iron, both of which are associated with poor thyroid function.
FIGURE 2: Preliminary Testing Including Serum Iron, Vitamin D, Lipids, C-Reactive Protein, and Homocysteine.
FIGURE 3: Small Intestinal Bacterial Overgrowth Breath Test Results.
Breath testing revealed the presence of bacterial overgrowth in the small intestine. The SIBO test is
based on this concept: an oral lactulose challenge will be fermented by small intestinal bacteria and
excreted by the body in the form of hydrogen and methane breath gases. Janel’s results showed high
methane and hydrogen breath gases.
SIBO may impair the absorption of several nutrients that are important for thyroid health, such as
zinc, selenium, and iodine. On the other hand, some studies have shown that hypothyroidism may
contribute to SIBO by decreasing intestinal motility.1 It is therefore difficult to know if SIBO caused
Janel’s hypothyroidism or if her hypothyroidism caused SIBO. 
FIGURE 4A: Comprehensive Stool Analysis & Parasitology from Doctor’s Data. Dysbiotic flora are highlighted in
red. Opportunistic, or imbalanced, flora are highlighted in yellow.
Janel’s stool test showed a 3+ growth for Citrobacter koseri, a species of bacteria that can be pathogenic when
overrepresented in the GI tract. Janel had adequate levels of beneficial flora (Bifidobacteria and Lactobacillus,
for example) but some imbalanced flora were accumulating (Pantoea species, Comamonas kerstersii, etc.). These
may or may not have contributed to her symptoms. No fungi or parasites were detected on her test.
FIGURE 4B: Comprehensive Stool Analysis & Parasitology (continued) Showing Markers of Digestion,
Inflammation, and Immune Function.
Janel’s stool test revealed elevations in lactoferrin and lysozyme. When significantly elevated, these markers are
indicative of active inflammatory bowel disease (IBD). When only mildly elevated, however, they often
represent inflammation secondary to pathogenic microbes or other causes. She had a very high secretory
immunoglobulin A (sIgA), a marker of immune function in the GI tract. This high level suggested that her
immune system was in overdrive, possibly due to bacterial overgrowth (C. koseri) or another underlying
inflammatory pathology. 
FIGURE 5: Urine Organic Acids from Great Plains Laboratory, Showing Markers of Bacterial and Yeast Metabolism.
Her urine organic acids test (OAT) had several markers for gut dysbiosis, particularly an overgrowth of
Clostridia species (HPHPA) that produce known neurotoxins and a marker that may be associated with
fungal overgrowth (5-hydroxymethyl-2-furoic acid). The SIBO, stool, and organic acids tests showed that
Janel had moderate dysbiosis (primarily bacterial). 
FIGURE 6: Analysis of HPA-axis Function Using the Dried Urine Test Comprehensive Hormones (DUTCH) from
Precision Analytical.
A hormone test assessing her hypothalamic-pituitary-adrenal (HPA) axis function revealed high free cortisol,
but low metabolized (total) cortisol. Janel’s free cortisol was 31 (range: 11–31) and her metabolized cortisol
was 2184 (range: 2240–4300). Hypothyroidism impairs the body’s ability to metabolize cortisol, so this
pattern of high free cortisol but low total metabolized cortisol suggested that Janel had poor thyroid function
and could not metabolize cortisol properly. This test also showed a disrupted diurnal cortisol rhythm. The
normal range is represented by the two black lines on the bar graph. Janel’s cortisol results, represented by the
red line, showed high cortisol in the morning, afternoon, and night samples.
As I reviewed Janel’s dietary survey, I noticed that she didn’t eat seafood or seaweed (because of an allergy),
and that she used sea salt rather than iodized salt. I also noted that she was consuming a green smoothie with
large amounts of raw kale every morning. Kale is a goitrogen that can inhibit iodine uptake in the thyroid
gland. Because of her low intake of iodine and high intake of raw kale, I suspected she was iodine deficient,
which I confirmed with a 24-hour urine iodine test.
For treatment, I started Janel on an iodine protocol and asked her to eat more selenium-rich food, such as
Brazil nuts. (She was already eating a “Paleo template” diet.) I told her to limit her goitrogenic foods to three
to six servings a week and make sure to cook those foods to reduce their effects on thyroid function. I also
prescribed a high-vitamin, extra-virgin cod liver oil to bring up her vitamin D levels (while also providing
vitamin A and omega-3 fatty acids).
I treated her SIBO, bacterial overgrowth, and inflammatory markers by using a botanical antimicrobial
protocol for 30 days. GI Synergy (Apex Energetics) and InterFase Plus (Klaire Labs) are designed to remove
bacteria, fungi, and parasites in the gastrointestinal tract. MegaSporeBiotic is a probiotic and antioxidant
formula that rebuilds beneficial gut bacteria but also has an antimicrobial effect (it contains Bacillus species
probiotics, which some pharmaceutical antibiotics have been isolated from). Because Janel had elevated
methane breath gases, I gave her Ideal Bowel Support (Jarrow Formulas), which is a beneficial bacteria
(Lactobacillus plantarum) that degrades methane.
I addressed her HPA axis dysregulation with a comprehensive program including circadian regulation
(controlling exposure to light during day and evening), stress management, adaptogens, and other nutrients to
support HPA axis function and improve cortisol metabolism.
Finally, I had her donate blood to reduce her iron levels into an optimal range.  
TABLE 1: Janel’s Treatment Protocol with Dosages.
Two tablets, once a day.

Iodine Kelp tablets NOW After three months, reduce
to one tablet, once a day.
1 packet BID (with breakfast

and dinner)
3-4 capsules BID on an

Antimicrobial InterFase Plus Klaire Labs
empty stomach
One BID upon rising and

before bed
Probiotic/antimi-
MegaSporeBiotic MegaSporeBio- tic One capsule with lunch
crobial
L. plantarum for
Probiotic Ideal Bowel Support Jarrow Formulas
methanogens
HPA axis support HPA Balance Vital Plan 2 caps twice daily with food
HPA axis support Kavinace Neuroscience 2 caps one hour before bed
1 cap three times daily with

HPA axis support Acetyl-CH Apex Energetics
food
After three months on this program, her hypothyroid symptoms had improved dramatically and her
TSH and other thyroid markers had normalized—without any medication at all (Figure 7).  
FIGURE 7: Thyroid Function Tests after Treatment.
Her HPA axis function improved, with normalization of her total free cortisol production as well as the free
cortisol diurnal rhythm. On her first test of HPA axis function, Janel had high free cortisol but low
metabolized cortisol. Her follow-up test showed a decreased total free cortisol of 14.0 (range: 11–31) and an
increased metabolized cortisol of 2625 (range: 2240–4300), placing her in the normal ranges for both results.
On her initial test, she also had high cortisol in the morning, afternoon, and night. After treatment, her
cortisol levels decreased and she had normal cortisol upon waking and in the morning, afternoon, and night.  
FIGURE 8: Analysis of HPA Axis Function Using the DUTCH Test after Treatment.
Janel no longer complained of cold hands and feet and her hair loss slowed down dramatically until it wasn’t
an issue anymore. She started having regular bowel movements. She was pleased and empowered to resolve
her thyroid condition without taking medications. 
iii
iii
iii
iii
References
1Patil, A. (2014). Link between hypothyroidism and small intestinal bacterial overgrowth. Indian Journal of
Endocrinology and Metabolism, 18(3), 307.

Unconventional Medicine Bonus Chapter

Uploaded by

Copyright:

Available Formats

Unconventional Medicine Bonus Chapter

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Unconventional Medicine Bonus Chapter

Uploaded by

Copyright:

Available Formats

How were Michelle's joint pain and other symptoms resolved?

How were Michelle's joint pain and other symptoms resolved?

What gut dysbiosis and other issues were found in Michelle's initial testing?

What gut dysbiosis and other issues were found in Michelle's initial testing?

UNCONVENTIONAL

Thank you for downloading the Unconventional Medicine bonus chapter.

FIGURE 2: HLA-B27 Blood Test.

The primary goals of the treatment protocol were:

TREATMENT NUTRACEUTICAL BRAND DOSAGE

FIGURE 8: Follow-up Test Results for SIBO.

Her follow-up SIBO results were normal.

FIGURE 11: Follow-up Results for DUTCH Test

Initial Presentation and Lab Testing

FIGURE 1: Thyroid Function Markers and Thyroid Antibodies.

FIGURE 4: Intrinsic Factor Antibody Test.

FIGURE 6: Small Intestinal Bacterial Overgrowth Breath Test Results.

Initial Treatment Plan

TREATMENT NUTRACEUTICAL BRAND DOSAGE

Microbial balance BroccoMax Jarrow Formulas 1 capsule TID with meals

Nutrition Trifolamin Designs for Health 1 lozenge (5 mg)/day

Nutrition Micellized Vitamin D3 Klaire Labs 10,000 IU/day

2 caps twice daily with

Sixty-Day Follow-up: Clinical Outcome and Additional Testing

FIGURE 11: Follow-up SIBO Test Results

Treatment Plan Modifications Made after 60 Days

120-Day Follow-up: Clinical Outcome and Additional Testing

Treatment Plan Modifications after 120 Days

Vitamin B12 and Pernicious Anemia

HPA Dysfunction and Diabetes

2 Malavolta M, Giacconi R, Piacenza F, et al. Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as

4 Shmuely H, Domniz N, Yahav J. Non-pharmacological treatment of Helicobacter pylori. World J Gastrointest

My panel of initial tests returned the following notable results.

TREATMENT NUTRACEUTICAL BRAND DOSAGE

Two tablets, once a day.

1 packet BID (with breakfast

3-4 capsules BID on an

One BID upon rising and

1 cap three times daily with

You might also like